A New Symbiosis For MD's And Scientists

Advances in molecular biology foster greater interdependency among physicians, researchers The province of the scientist traditionally has been one of theory and experiment, exploration and discovery--contrasting sharply with the practical concerns of the physician. But times have changed. Today, physicians find themselves in need of knowledge in such esoteric matters as the polymerase chain reaction and restriction fragment-length polymorphism maps. Meanwhile, scientists are having to acqua

Written byRicki Lewis
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Today, physicians find themselves in need of knowledge in such esoteric matters as the polymerase chain reaction and restriction fragment-length polymorphism maps. Meanwhile, scientists are having to acquaint themselves with the world beyond the lab--talking, for instance, to the families who supply the DNA samples stored in their refrigerators, a task generally left up to clinicians. Increasingly, lines that traditionally separate the researcher and physician are blurring.

Crossover between the professions is still unusual, however; of 600,000 physicians in the United States, only 16,560 are involved in clinical research, according to the American Medical Association.

The M.D.-Ph.D. dual degree is one approach to bridging the gap (The Scientist, April 13, 1992, page 12)--and many professionals on both sides are pushing for a graceful, effective union between the heretofore disjunct pursuits.

However, while 111 United States schools offer M.D.-Ph.D. programs, many physicians eschew that route as they strive to hone their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies